Relapsed Refractory Multiple Myeloma (RRMM), Lenalidomide Exposed, 1,2,3,>=4 prior line of therapy, Phase 3, Daratumumab+Pomalidomide+Dexamethasone (DPd), Anti-CD38 MAb, Pomalidomide+Dexamethasone (Pd)
### Instruction:
Identify the study with the following condition. 
### Input:
Relapsed Refractory Multiple Myeloma (RRMM), Lenalidomide Exposed, 1,2,3,>=4 prior line of therapy, Phase 3, Daratumumab+Pomalidomide+Dexamethasone (DPd), Anti-CD38 MAb, Pomalidomide+Dexamethasone (Pd) 
### Output:
Popular Name is APOLLO, Study ID is NCT03180736